Guan Wang

No 40 Songpo Road
Jinzhou, 121001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Retraction Note: The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M.

Retraction Note: The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M.

Journal: BMC cancer
Published: August 08, 2026

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.

Journal: Molecular oncology
Published: March 04, 2025

Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia.

Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia.

Journal: Investigational new drugs
Published: February 18, 2025

Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia.

Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia.

Journal: Investigational new drugs
Published: December 13, 2024

ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress.

ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress.

Journal: Journal of experimental & clinical cancer research : CR
Published: October 17, 2024

Synergistic effect of adavosertib and fimepinostat on acute myeloid leukemia cells by enhancing the induction of DNA damage.

Synergistic effect of adavosertib and fimepinostat on acute myeloid leukemia cells by enhancing the induction of DNA damage.

Journal: Investigational new drugs
Published: September 28, 2023

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia.

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia.

Journal: Cancer research
Published: September 06, 2023

Title: Serious COVID-19 may have a causal relationship with myocardial injury: A Mendelian randomization study.

Title: Serious COVID-19 may have a causal relationship with myocardial injury: A Mendelian randomization study.

Journal: Frontiers in genetics
Published: January 02, 2023

Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia.

Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia.

Journal: Neoplasma
Published: December 17, 2022

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia.

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia.

Journal: Cells
Published: August 04, 2022

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia.

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia.

Journal: Apoptosis : an international journal on programmed cell death
Published: July 10, 2022

Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.

Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.

Journal: Frontiers in oncology
Published: May 25, 2022
Showing 1-12 of 45

Last Updated: 09/26/2026